PTBP3 and pancreatic adenocarcinoma: PTBP3 was significantly associated with poor prognosis in ACC, LGG, PAAD, and PCPG (HR > 1, p < 0.05), but predicted better prognosis in KICH and KIRC (HR < 1, p < 0.05).